The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 08, 2021

Filed:

Oct. 07, 2016
Applicant:

Editas Medicine, Inc., Cambridge, MA (US);

Inventors:

Deepak Reyon, Malden, MA (US);

Morgan L. Maeder, Jamaica Plain, MA (US);

Ari E. Friedland, Boston, MA (US);

G. Grant Welstead, Cambridge, MA (US);

David A. Bumcrot, Blemont, MA (US);

Assignee:

EDITAS MEDICINE, INC., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); C12N 9/22 (2006.01);
U.S. Cl.
CPC ...
C12N 15/1138 (2013.01); C12N 9/22 (2013.01); C12N 2310/10 (2013.01); C12N 2310/20 (2017.05); C12N 2320/34 (2013.01);
Abstract

Disclosed herein are genome editing systems and compositions that target a cystic fibrosis transmembrane conductance regulator (CFTR) gene and a sodium channel epithelial 1 alpha (SCNN1A) gene, comprising a Cas9 molecule, and a gRNA molecule comprising a targeting domain that is complementary with a target sequence of a CFTR gene or a SCNN1A gene, and cells comprising such genome editing systems and compositions. Also provided are methods for using the genome editing systems, compositions, and cells for genome engineering (e.g., altering a CFTR gene and/or a SCNN1A gene), and for preventing or treating Cystic Fibrosis (CF) and CF-like disease.


Find Patent Forward Citations

Loading…